求助PDF
{"title":"[Prise en charge de l'iléostomie à haut débit chez les personnes âgées : une revue systématique de cas et de séries de cas].","authors":"Romain Hertzog, Moustapha Dramé, Lidvine Godaert","doi":"10.1684/pnv.2024.1150","DOIUrl":null,"url":null,"abstract":"<p><p>The aim was to perform a systematic review of cases published in the literature to describe the management of high-output ileostomy (HOI) in older adults. A literature search was performed in PubMed©, and Scopus© for all publications up to March 1st, 2023. Case reports and/or case series reporting data from older adults on HOI management were included. Publication year, country, sex, age, aetiology of the stomy, time from ileostomy to HOI, daily volume threshold, Treatment regimen, and effectiveness were extracted. In total, 428 studies were identified, of which 9 (describing 10 cases) were included in this review. The mean age was 69.9 ± 4.7 years. The most frequent aetiology of ileostomy was occlusion. The daily volume considered to be excessive ranged from 1 to 2 litres per 24-hour period. The main side effects of HOI were dehydration, acute renal failure, and weight loss. Loperamide was the most frequently used drug. Most studies reported that non-pharmacological therapies were also used. No death was reported in any of the studies. In all, ileostomy exposes older individuals to complications. Medical therapy with loperamide coupled with rehydration seems to be efficacious in the medium term. Multidisciplinary management is advisable, in order to increase the chances of achieving ostomy reversal as early as possible, when indicated.</p>","PeriodicalId":51244,"journal":{"name":"Geriatrie et Psychologie Neuropsychiatrie De Vieillissement","volume":null,"pages":null},"PeriodicalIF":0.4000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Geriatrie et Psychologie Neuropsychiatrie De Vieillissement","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1684/pnv.2024.1150","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0
引用
批量引用
Abstract
The aim was to perform a systematic review of cases published in the literature to describe the management of high-output ileostomy (HOI) in older adults. A literature search was performed in PubMed©, and Scopus© for all publications up to March 1st, 2023. Case reports and/or case series reporting data from older adults on HOI management were included. Publication year, country, sex, age, aetiology of the stomy, time from ileostomy to HOI, daily volume threshold, Treatment regimen, and effectiveness were extracted. In total, 428 studies were identified, of which 9 (describing 10 cases) were included in this review. The mean age was 69.9 ± 4.7 years. The most frequent aetiology of ileostomy was occlusion. The daily volume considered to be excessive ranged from 1 to 2 litres per 24-hour period. The main side effects of HOI were dehydration, acute renal failure, and weight loss. Loperamide was the most frequently used drug. Most studies reported that non-pharmacological therapies were also used. No death was reported in any of the studies. In all, ileostomy exposes older individuals to complications. Medical therapy with loperamide coupled with rehydration seems to be efficacious in the medium term. Multidisciplinary management is advisable, in order to increase the chances of achieving ostomy reversal as early as possible, when indicated.
[老年人高流量回肠造口术的管理:病例和系列病例的系统回顾]。
目的是对文献中发表的病例进行系统性回顾,以描述老年人高排量回肠造口术(HOI)的治疗方法。我们在 PubMed© 和 Scopus© 上检索了截至 2023 年 3 月 1 日的所有文献。包括病例报告和/或报告老年人高排量回肠造口术管理数据的系列病例。提取了发表年份、国家、性别、年龄、造口病因、从回肠造口术到 HOI 的时间、每日容量阈值、治疗方案和有效性。总共确定了 428 项研究,其中 9 项(描述了 10 个病例)被纳入本综述。平均年龄为 69.9 ± 4.7 岁。回肠造口术最常见的病因是闭塞。每天 24 小时的排便量被认为过多,从 1 升到 2 升不等。回肠造口术的主要副作用是脱水、急性肾功能衰竭和体重下降。洛哌丁胺是最常用的药物。大多数研究报告称也使用了非药物疗法。所有研究均未报告死亡病例。总之,回肠造口术使老年人面临并发症的风险。使用洛哌丁胺配合补液的药物疗法似乎在中期有效。建议采用多学科管理,以增加在有指征时尽早实现造口逆转的机会。
本文章由计算机程序翻译,如有差异,请以英文原文为准。